Pronase used for the treatment of diseases of the liver and kidneys in humans and animals
AssigneeKaken Pharmaceutical Co., Ltd.
InventorsShigemi Fujisaki, Mitsuaki Mitani
Life of this patent
Estimating the term…
Abstract
Diseases of the liver and kidneys in humans and animals may be prevented and treated by administering a therapeutically effective amount of a member selected from the group consisting of one or more proteolytic enzymes, one or more polysaccharide mucopolysaccharide-lysing enzymes, and mixtures thereof, in combination with a pharmaceutically acceptable carrier.
Claims3
A method of treating chronic hepatitis, chronic glomerulonephritis and nephrotic syndromes in humans and animals which comprises administering to a human or animal in need thereof, a therapeutically effective amount of pronase in combination with a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.